Holen Sie sich die Stockscreener-App
76.52
5.05%
3.68
Praxis Precision Medicines Inc Aktie (PRAX) Neueste Nachrichten
Franklin Resources Inc. Grows Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
State Street Corp Has $45.44 Million Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $913,000 Stock Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World
(PRAX) Technical Data - Stock Traders Daily
Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine - The Bakersfield Californian
Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome - GlobeNewswire
Praxis Precision Medicines Secures Key FDA Designation for Promising Epilepsy Drug Relutrigine - StockTitan
Praxis Precision Medicines (NASDAQ:PRAX) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Wellington Management Group LLP Buys 168,394 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Praxis Precision Medicines’ (PRAX) Buy Rating Reiterated at HC Wainwright - Defense World
BNP Paribas Financial Markets Purchases 7,496 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for Praxis Precision Medicines (NASDAQ:PRAX) - MarketBeat
Expert Ratings For Praxis Precision Medicine - Benzinga
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat
Fmr LLC Trims Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Jefferies highlights Praxis Medicines as a 'top idea' for 2025, raises price target - Investing.com
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Where are the Opportunities in (PRAX) - Stock Traders Daily
Jacobs Levy Equity Management Inc. Cuts Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Janus Henderson Group PLC Purchases 141,881 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Praxis Precision management to meet with Oppenheimer - Nasdaq
RA Capital Management L.P. Has $43.84 Million Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
HighVista Strategies LLC Makes New $630,000 Investment in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Praxis Precision Medicines to Present at Upcoming December Investor Conferences - The Manila Times
Praxis Precision Medicines to Present at Major Healthcare Investor Conferences in December - StockTitan
Walleye Capital LLC Buys New Shares in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Baker BROS. Advisors LP Has $18.59 Million Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Fred Alger Management LLC Buys 7,828 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
PRAX (Praxis Precision Medicines) Shares Outstanding (EOP) : 17.79 Mil (As of Sep. 2024) - GuruFocus.com
Verition Fund Management LLC Lowers Stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
PRAX (Praxis Precision Medicines) Debt-to-EBITDA : -0.01 (As of Sep. 2024) - GuruFocus.com
Ally Bridge Group NY LLC Sells 80,194 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Sold by Acuta Capital Partners LLC - MarketBeat
Long Term Trading Analysis for (PRAX) - Stock Traders Daily
Praxis Precision Medicines to Showcase Updates from Largest - GlobeNewswire
Praxis Precision Medicines to Showcase Updates from Largest Epilepsy Pipeline of Precision Epilepsy Programs at the 2024 American Epilepsy Society Annual Meeting - The Manila Times
Why Praxis Precision Medicines Stock Is Trading Higher Tuesday - MSN
Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down After Insider Selling - MarketBeat
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Bought by CIBC Asset Management Inc - MarketBeat
Alex Nemiroff Sells 8,239 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Stock - MarketBeat
Insider Selling: Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Insider Sells 5,188 Shares of Stock - MarketBeat
(PRAX) Proactive Strategies - Stock Traders Daily
Praxis Precision Medicines' general counsel sells shares worth $660,827 - Investing.com India
Praxis Precision Medicines principal accounting officer sells $424,318 in stock By Investing.com - Investing.com Australia
Praxis Precision Medicines principal accounting officer sells $424,318 in stock - Investing.com
Praxis Precision Medicines (NASDAQ:PRAX) Trading Down 7.9%Should You Sell? - MarketBeat
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Cormorant Asset Management's Strategic Acquisition in Praxis Pre - GuruFocus.com
Verition Fund Management LLC Adjusts Stake in Praxis Precision M - GuruFocus.com
Capital Research Global Investors Acquires New Stake in Praxis P - GuruFocus.com
What is HC Wainwright's Estimate for PRAX FY2024 Earnings? - MarketBeat
Equities Analysts Offer Predictions for PRAX FY2024 Earnings - MarketBeat
Praxis Precision Medicines Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
HC Wainwright Reiterates "Buy" Rating for Praxis Precision Medicines (NASDAQ:PRAX) - MarketBeat
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):